Trials / Completed
CompletedNCT07018908
Effect of Intake of Dehydrated Nopal Powder From Highly Mature Cladodes on the Lipid Profile
Effect of Intake of Dehydrated Nopal Powder From Highly Mature Cladodes (Opuntia Ficus-indica) on the Lipid Profile of Overweight or Obese Adults. A Randomized Controlled Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (actual)
- Sponsor
- Universidad Autónoma de Querétaro · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Background: Opuntia ficus-indica is a plant from the cactus family (Cactaceae) that is widespread and of great economic importance in Mexico. It has been consumed as food since pre-Hispanic times and is currently considered a nutraceutical. In this study, the effect of consumption of dehydrated nopal powder from highly mature cladodes (Opuntia ficus-indica) on the lipid profile of overweight or obese patients diagnosed with dyslipidemia was investigated. Methods: A 3-month prospective clinical trial was conducted in 35 overweight or obese patients with dyslipidemia. The sample was divided into three groups with a daily intake of 30 g of dietary fiber: Group I received 5 g of dehydrated Opuntia ficus-indica cladodes plus the standard normocaloric diet for dyslipidemia, Group II received 15 g plus the diet, and Group III followed only the diet.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | supplementation with 5 g dehydrated nopal powder from highly mature cladodes | Group I received 5 g of dehydrated Opuntia ficus-indica cladodes plus the standard normocaloric diet for dyslipidemia. |
| DIETARY_SUPPLEMENT | supplementation with 15 g dehydrated nopal powder from highly mature cladodes | Group II received 15 g plus the diet, and Group III followed only the diet. |
| OTHER | Control Group (only diet) | No dehydrated nopal or placebo. Diet: 30 g of fiber per day Normocaloric diet Carbohydrates 55%, Lipids 25% and Proteins 20% |
Timeline
- Start date
- 2018-06-01
- Primary completion
- 2018-12-15
- Completion
- 2019-05-01
- First posted
- 2025-06-13
- Last updated
- 2025-06-13
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT07018908. Inclusion in this directory is not an endorsement.